These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 24364582

  • 1. FPIN's clinical inquiries. Testosterone therapy and risk recurrence after treatment of prostate cancer.
    Meza J, Weaver K, Martin S.
    Am Fam Physician; 2013 Oct 15; 88(8):Online. PubMed ID: 24364582
    [No Abstract] [Full Text] [Related]

  • 2. Do we have enough evidences that make you safe to treat a man with hypogonadism one year after a radical prostatectomy for prostate cancer? | Opinion: YES.
    Torres LO.
    Int Braz J Urol; 2018 Oct 15; 44(1):4-7. PubMed ID: 29424506
    [No Abstract] [Full Text] [Related]

  • 3. Do we have enough evidences that make you safe to treat a man with hypogonadism one year after a radical prostatectomy for prostate cancer? | Opinion: Not Yet.
    Wroclawski ML, Heldwein FL.
    Int Braz J Urol; 2018 Oct 15; 44(1):8-13. PubMed ID: 29424507
    [No Abstract] [Full Text] [Related]

  • 4. Testosterone administration in older men.
    Matsumoto AM.
    Endocrinol Metab Clin North Am; 2013 Jun 15; 42(2):271-86. PubMed ID: 23702401
    [Abstract] [Full Text] [Related]

  • 5. Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes.
    Kaplan AL, Hu JC.
    Urology; 2013 Aug 15; 82(2):321-6. PubMed ID: 23706552
    [Abstract] [Full Text] [Related]

  • 6. A new testosterone gel (fortesta) for hypogonadism.
    Med Lett Drugs Ther; 2011 Apr 18; 53(1362):29-30. PubMed ID: 21502933
    [Abstract] [Full Text] [Related]

  • 7. [Prostate carcinoma and testosterone: risks and controversies].
    Rhoden EL, Averbeck MA.
    Arq Bras Endocrinol Metabol; 2009 Nov 18; 53(8):956-62. PubMed ID: 20126847
    [Abstract] [Full Text] [Related]

  • 8. Testosterone replacement therapy. A rush to judgment?
    Loughlin KR.
    J Urol; 2004 Sep 18; 172(3):827-8. PubMed ID: 15310977
    [No Abstract] [Full Text] [Related]

  • 9. Testosterone replacement therapy and the risk of prostate cancer.
    Warburton D, Hobaugh C, Wang G, Lin H, Wang R.
    Asian J Androl; 2015 Sep 18; 17(6):878-81; discussion 880. PubMed ID: 25865848
    [Abstract] [Full Text] [Related]

  • 10. Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men.
    Kaufman JM, Graydon RJ.
    J Urol; 2004 Sep 18; 172(3):920-2. PubMed ID: 15310998
    [Abstract] [Full Text] [Related]

  • 11. Assessment and management of male androgen disorders: an update.
    Chan I, Fui MN, Zajac JD, Grossmann M.
    Aust Fam Physician; 2014 May 18; 43(5):277-82. PubMed ID: 24791767
    [Abstract] [Full Text] [Related]

  • 12. [Testosterone replacement therapy for hypogonadism in men with prostate cancer].
    Jensen CF, Fode M, Østergren P, Sønksen J.
    Ugeskr Laeger; 2017 Feb 27; 179(9):. PubMed ID: 28263152
    [Abstract] [Full Text] [Related]

  • 13. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM, Simhan J, Carson CC.
    BJU Int; 2009 May 27; 103(9):1179-83. PubMed ID: 19154450
    [Abstract] [Full Text] [Related]

  • 14. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
    Johansen KL.
    Semin Dial; 2004 May 27; 17(3):202-8. PubMed ID: 15144546
    [Abstract] [Full Text] [Related]

  • 15. Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
    Gould DC, Kirby RS.
    Prostate Cancer Prostatic Dis; 2006 May 27; 9(1):14-8. PubMed ID: 16264770
    [Abstract] [Full Text] [Related]

  • 16. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
    Sarosdy MF.
    Cancer; 2007 Feb 01; 109(3):536-41. PubMed ID: 17183557
    [Abstract] [Full Text] [Related]

  • 17. Androgen replacement therapy in aging men.
    Katz A.
    Nurse Pract; 2004 Oct 01; 29(10):58-64. PubMed ID: 15489672
    [No Abstract] [Full Text] [Related]

  • 18. [Testosterone replacement therapy for late-onset hypogonadism after radical prostatectomy: a case report].
    Nakano K, Kiuchi H, Miyagawa Y, Tsujimura A, Nonomura N.
    Hinyokika Kiyo; 2014 Aug 01; 60(8):397-400. PubMed ID: 25179991
    [Abstract] [Full Text] [Related]

  • 19. Registry of Hypogonadism in Men (RHYME): design of a multi-national longitudinal, observational registry of exogenous testosterone use in hypogonadal men.
    Rosen RC, Wu FC, Behre HM, Roehrborn CG, Schröder FH, Siami FS, Martha JF, Finn JD, Araujo AB.
    Aging Male; 2013 Mar 01; 16(1):1-7. PubMed ID: 23373674
    [Abstract] [Full Text] [Related]

  • 20. [Hypogonadism - testosterone replacement therapy after prostate cancer?].
    van Essen J, Pfister D, Heidenreich A.
    Aktuelle Urol; 2014 Jan 01; 45(1):17-8. PubMed ID: 24500954
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.